Experimental Animal Research in Vaccine Studies during the Pandemic Process

S. Aktaş
{"title":"Experimental Animal Research in Vaccine Studies during the Pandemic Process","authors":"S. Aktaş","doi":"10.30607/kvj.1423417","DOIUrl":null,"url":null,"abstract":"The pandemic that emerged in Wuhan, China, in 2019, once again revealed the role of basic sciences and experimental animal research in the world. This situation, also called COVID-19, has spread rapidly all over the world in a short period of 3 months. It has been revealed that vaccination is more important than treatment in reducing mass deaths during the fight against the pandemic. The fact that RNA viruses constantly change their genetic properties was also a major challenge in finding an effective vaccine. However, increasing progress in basic sciences (especially mRNA technology) and the use of humanized mice have contributed greatly to reducing mass deaths. The fact that the Sars-Cov-2 virus does not cause infection in conventional mice and that it can create an infection model in mutant mice to which human lung epithelial genes are transferred has given great impetus to vaccine and new drug treatment studies. The first vaccine model was developed using these mice in vaccine studies. Nearly 176 vaccine types have been developed in the Covid-19 pandemic. These vaccines; viron vaccines are nucleic acid-based (mRNA), viral vector and protein-based vaccines. The mutant mice used in the first step of these vaccines created the disease model almost perfectly and ensured that the results in the target species (Human) progressed with fewer errors. Since the disease occurs in mice carrying human lung epithelium very close to the target species, they have played a major role in testing the protective effects of vaccines. The vaccines prepared towards the end of 2020 were made ready for use. Vaccine production has been carried out at an almost record speed in pandemics in world history. Although vaccines may have different effects and protection levels, the role of vaccines in the pandemic is undeniable. More than 2.5 billion doses of COVID-19 vaccines have been administered worldwide, and approximately 35 million doses continue to be administered every day. Experimental animal research, genetic research and gene transfer that started in the 1970s were used to obtain vaccines that were prepared in a short time and made available to humanity. technologies and mutant mouse technology play a huge role. Although the pandemic process is still not over, it is expected to ease and continue to have effects similar to seasonal flu. In this process, humanity has gained important experience in acting together and rapid vaccine development. The use of experimental animals is of great importance in these processes.","PeriodicalId":506171,"journal":{"name":"Kocatepe Veterinary Journal","volume":"9 16","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kocatepe Veterinary Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30607/kvj.1423417","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The pandemic that emerged in Wuhan, China, in 2019, once again revealed the role of basic sciences and experimental animal research in the world. This situation, also called COVID-19, has spread rapidly all over the world in a short period of 3 months. It has been revealed that vaccination is more important than treatment in reducing mass deaths during the fight against the pandemic. The fact that RNA viruses constantly change their genetic properties was also a major challenge in finding an effective vaccine. However, increasing progress in basic sciences (especially mRNA technology) and the use of humanized mice have contributed greatly to reducing mass deaths. The fact that the Sars-Cov-2 virus does not cause infection in conventional mice and that it can create an infection model in mutant mice to which human lung epithelial genes are transferred has given great impetus to vaccine and new drug treatment studies. The first vaccine model was developed using these mice in vaccine studies. Nearly 176 vaccine types have been developed in the Covid-19 pandemic. These vaccines; viron vaccines are nucleic acid-based (mRNA), viral vector and protein-based vaccines. The mutant mice used in the first step of these vaccines created the disease model almost perfectly and ensured that the results in the target species (Human) progressed with fewer errors. Since the disease occurs in mice carrying human lung epithelium very close to the target species, they have played a major role in testing the protective effects of vaccines. The vaccines prepared towards the end of 2020 were made ready for use. Vaccine production has been carried out at an almost record speed in pandemics in world history. Although vaccines may have different effects and protection levels, the role of vaccines in the pandemic is undeniable. More than 2.5 billion doses of COVID-19 vaccines have been administered worldwide, and approximately 35 million doses continue to be administered every day. Experimental animal research, genetic research and gene transfer that started in the 1970s were used to obtain vaccines that were prepared in a short time and made available to humanity. technologies and mutant mouse technology play a huge role. Although the pandemic process is still not over, it is expected to ease and continue to have effects similar to seasonal flu. In this process, humanity has gained important experience in acting together and rapid vaccine development. The use of experimental animals is of great importance in these processes.
疫苗大流行过程中的实验动物研究
2019 年在中国武汉出现的大流行病再次揭示了基础科学和实验动物研究在世界上的作用。这种情况也被称为 COVID-19,在短短 3 个月内迅速蔓延到世界各地。事实表明,在抗击大流行病的过程中,接种疫苗比治疗更能减少大规模死亡。RNA 病毒会不断改变其遗传特性,这也是寻找有效疫苗的一大挑战。然而,基础科学(尤其是 mRNA 技术)的不断进步和人源化小鼠的使用为减少大规模死亡做出了巨大贡献。Sars-Cov-2 病毒不会引起常规小鼠的感染,而且可以在转入人类肺上皮基因的变异小鼠中建立感染模型,这一事实极大地推动了疫苗和新药治疗研究。在疫苗研究中,利用这些小鼠建立了第一个疫苗模型。在 Covid-19 大流行中已开发出近 176 种疫苗。这些疫苗包括核酸疫苗(mRNA)、病毒载体疫苗和蛋白质疫苗。这些疫苗第一步使用的突变小鼠几乎完美地创建了疾病模型,并确保目标物种(人类)的研究结果进展顺利,错误较少。由于这种疾病发生在携带人类肺上皮细胞的小鼠身上,与目标物种非常接近,因此它们在测试疫苗的保护效果方面发挥了重要作用。2020 年底制备的疫苗已可投入使用。在世界历史上的大流行病中,疫苗生产的速度几乎是创纪录的。尽管疫苗的效果和保护水平各不相同,但疫苗在大流行中的作用是不可否认的。全世界已接种超过 25 亿剂 COVID-19 疫苗,每天仍在继续接种约 3500 万剂。20 世纪 70 年代开始的实验动物研究、基因研究和基因转移被用于获得疫苗,这些疫苗在很短的时间内就被制备出来并提供给人类使用。尽管大流行过程仍未结束,但预计会有所缓解,并继续产生类似季节性流感的影响。在这一过程中,人类获得了共同行动和快速开发疫苗的重要经验。在这些过程中,实验动物的使用具有重要意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信